Performance evaluation of interim analysis in bioequivalence studies.
Authors:
Preprint
- 25 January 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Under current bioequivalence guidelines in Japan, it is mandatory to establish bioequivalence using a single pivotal study. Clinical trials with limited resources usually have a pre-defined maximum permissible number of participants. In this manuscript, we considered a trial design that would allow for bioequivalence evaluation at an interim analysis in which the total number of participants takes into account the resource constraints. Then, available options at the interim analysis are group sequential designs and adaptive designs, A comparison of the performance of the two methods under a fixed maximum participant number has not been conducted thus far. So we examined which method should be used by conducting a simulation study. Since bioequivalence is expected to be achieved at the interim analysis, a study design using a Pocock-type alpha spending function is preferrable. Simulation results using a Pocock-type alpha spending function showed similar performance between group sequential and adaptive designs. Consequently, due to statistical and operational complexity, it is preferable to choose group sequential designs for bioequivalence study in Japan.Keywords
All Related Versions
This publication has 8 references indexed in Scilit:
- Two‐stage designs for cross‐over bioequivalence trialsStatistics in Medicine, 2015
- Two-stage designs in bioequivalence trialsEuropean Journal of Clinical Pharmacology, 2015
- On the statistical model of the two-stage designs in bioequivalence assessmentJournal of Pharmacy and Pharmacology, 2014
- Futility Rules in Bioequivalence Trials with Sequential DesignsThe AAPS Journal, 2013
- An Insight into the Properties of a Two-Stage Design in Bioequivalence StudiesPharmaceutical Research, 2013
- Sequential design approaches for bioequivalence studies with crossover designsPharmaceutical Statistics, 2007
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- A Multiple Testing Procedure for Clinical TrialsBiometrics, 1979